4Sc AG logo

VSC - 4Sc AG News Story

€1.41 0.0  2.2%

Last Trade - 4:36pm

Sector
Healthcare
Size
Small Cap
Market Cap £59.9m
Enterprise Value £30.2m
Revenue £1.93m
Position in Universe 795th / 1053

BRIEF-4Sc: FDA Accepts IND Application For MERKLIN 2 Study

Wed 8th April, 2020 6:40am
April 8 (Reuters) - 4SC AG  VSCk.DE :
    * FDA ACCEPTS IND APPLICATION FOR MERKLIN 2 STUDY
    * INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR
DOMATINOSTAT IN
COMBINATION WITH AVELUMAB (BAVENCIO(R)) HAS BEEN ACCEPTED BY
U.S. FOOD AND DRUG ADMINISTRATION (FDA)

Source text for Eikon:  ID:nEQ9ZFv6Ta 
Further company coverage:  VSCk.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.